In the present study, the outcomes of conventional clotting tests and anti-factor Xa chromogenic assays in Japanese stroke patients taking rivaroxaban were evaluated to assess the anticoagulation intensity of rivaroxaban and explore its determinant factors. This evidence concerns the gene F10 and stroke disorder.